Skip to main content
Thomas Gajewski

Thomas Gajewski

Thomas Gajewski is the AbbVie Foundation Professor of Cancer Immunotherapy at the University of Chicago, a physician-scientist and oncologist pioneering research into using the gut microbiome to fight cancer.

Aug 20, 2026

16:23
For those 50% or so that they're not getting a benefit, w- how do you tell them why their body is not responding the way you hoped it would?
16:32
Yeah.
16:33
So that's, uh, that's the, uh, next level nut to crack.
16:37
This is where most of our research effort is invested.
16:41
So, uh, most of the treatment failures are in patients who have, uh, this cold tumor phenotype, meaning the, uh, the good immune cells have not been allowed to enter the tumor microenvironment.
16:54
And, um, so if they're not there, they can't do their work, right, of, of recognizing and killing tumor cells.
17:01
And so, um, the, we've spent a lot of time thinking about that, you know, the last 10 or more years, 12 years.

9 MINS LATER

26:12
And, and, and so I guess this, the, the question, does this change or should it change the way that I'm eating? And especially if I'm being treated for cancer, do I need to be thinking, um, I should be h- eating more fermented foods, for example?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.